Immunome (IMNM) Other Accumulated Expenses (2020 - 2026)
Immunome's Other Accumulated Expenses was $3.23 million in Q2 2026, down 69.4% from $10.56 million a year earlier but up 1.7% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Immunome came in at $3.63 million, down 54.6% from FY2024.
- Other Accumulated Expenses shows a five-year compound annual growth rate of 104.7% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $7.98 million in FY2024 (+344.7%), $1.79 million in FY2023 (-20.7%), $2.26 million in FY2022 (+81.5%) and $1.25 million in FY2021.
- Quarterly Other Accumulated Expenses has moved between $713,000 (Q3 2023) and $18.08 million (Q3 2024) over five years.
- Compared with a year earlier, Other Accumulated Expenses has declined for five straight quarters, with growth averaging 28.4% over the last seven quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2024 (growth of 630.2%); the worst was Q1 2026 (a decline of 74.5%).
- Per Business Quant data, IMNM's Other Accumulated Expenses in the three quarters before Q2 2026 was $3.18 million (Q1 2026), $3.63 million (Q4 2025) and $15.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Immunome | 2.37 Bn | 341.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 15.59 Mn |
| Jun 30, 2025 | 10.56 Mn |
| Mar 31, 2025 | 12.46 Mn |
| Dec 31, 2024 | 7.98 Mn |
| Sep 30, 2024 | 18.08 Mn |
| Jun 30, 2024 | 14.46 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 713,000.00 |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 3.97 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 2.52 Mn |
API Access
Immunome Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();